- Home
- PHAR vs FMNB Comparison
PHAR vs FMNB Comparison
Compare PHAR & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- FMNB
- Stock Information
- Founded
- PHAR 1988
- FMNB 1887
- Country
- PHAR Netherlands
- FMNB United States
- Employees
- PHAR N/A
- FMNB N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- PHAR Health Care
- FMNB Finance
- Exchange
- PHAR Nasdaq
- FMNB Nasdaq
- Market Cap
- PHAR 731.1M
- FMNB 503.3M
- IPO Year
- PHAR N/A
- FMNB N/A
- Fundamental
- Price
- PHAR $10.00
- FMNB $14.06
- Analyst Decision
- PHAR Strong Buy
- FMNB Hold
- Analyst Count
- PHAR 3
- FMNB 3
- Target Price
- PHAR $30.00
- FMNB $15.33
- AVG Volume (30 Days)
- PHAR 3.6K
- FMNB 118.5K
- Earning Date
- PHAR 07-31-2025
- FMNB 07-23-2025
- Dividend Yield
- PHAR N/A
- FMNB 4.81%
- EPS Growth
- PHAR N/A
- FMNB N/A
- EPS
- PHAR N/A
- FMNB 1.28
- Revenue
- PHAR $320,708,000.00
- FMNB $166,505,000.00
- Revenue This Year
- PHAR $13.31
- FMNB $19.04
- Revenue Next Year
- PHAR $7.68
- FMNB $4.36
- P/E Ratio
- PHAR N/A
- FMNB $11.04
- Revenue Growth
- PHAR 24.13
- FMNB N/A
- 52 Week Low
- PHAR $6.65
- FMNB $11.58
- 52 Week High
- PHAR $12.61
- FMNB $16.32
- Technical
- Relative Strength Index (RSI)
- PHAR 43.61
- FMNB 55.52
- Support Level
- PHAR $9.99
- FMNB $14.26
- Resistance Level
- PHAR $10.59
- FMNB $14.77
- Average True Range (ATR)
- PHAR 0.35
- FMNB 0.30
- MACD
- PHAR -0.14
- FMNB 0.06
- Stochastic Oscillator
- PHAR 7.45
- FMNB 63.02
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.